PubMed

Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease.

Rountree SD, Chan W, Pavlik VN, Darby EJ, Siddiqui S, Doody RS.

Alzheimers Res Ther. 2009 Oct 21;1(2):7.PMID: 19845950 [PubMed]Free PMC ArticleFree textRelated citations

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.

Wilcock GK, Black SE, Hendrix SB, Zavitz KH, Swabb EA, Laughlin MA; Tarenflurbil Phase II Study investigators.

Lancet Neurol. 2008 Jun;7(6):483-93. Epub 2008 Apr 29. Erratum in: Lancet Neurol. 2008 Jul;7(7):575. PMID: 18450517 [PubMed - indexed for MEDLINE]Related citations

Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.

Santoro A, Siviero P, Minicuci N, Bellavista E, Mishto M, Olivieri F, Marchegiani F, Chiamenti AM, Benussi L, Ghidoni R, Nacmias B, Bagnoli S, Ginestroni A, Scarpino O, Feraco E, Gianni W, Cruciani G, Paganelli R, Di Iorio A, Scognamiglio M, Grimaldi LM, Gabelli C, Sorbi S, Binetti G, Crepaldi G, Franceschi C.

CNS Drugs. 2010 Feb 1;24(2):163-76. doi: 10.2165/11310960-000000000-00000.PMID: 20088621 [PubMed - indexed for MEDLINE]Related citations

Donepezil for vascular cognitive impairment.

Malouf R, Birks J.

Cochrane Database Syst Rev. 2004;(1):CD004395. Review.PMID: 14974068 [PubMed - indexed for MEDLINE]Related citations

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747. PMID: 11687119 [PubMed - indexed for MEDLINE]Related citations

Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).

Hanon O, Latour F, Seux ML, Lenoir H, Forette F, Rigaud AS; REAL.FR Group.

J Nutr Health Aging. 2005;9(2):106-11.PMID: 15791354 [PubMed - indexed for MEDLINE]Related citations

Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study.

Cortes F, Nourhashémi F, Guérin O, Cantet C, Gillette-Guyonnet S, Andrieu S, Ousset PJ, Vellas B; REAL-FR Group.

Alzheimers Dement. 2008 Jan;4(1):22-9.PMID: 18631947 [PubMed - indexed for MEDLINE]Related citations

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.

Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ; Alzheimer's Disease Cooperative Study.

JAMA. 2003 Jun 4;289(21):2819-26.PMID: 12783912 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2002;(3):CD001747. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD001747. PMID: 12137632 [PubMed - indexed for MEDLINE]Related citations

Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.

Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Petanceska S, Browne P, Wassar D, Johnson-Traver S, Lochhead J, Ziolkowski C.

Curr Alzheimer Res. 2005 Jul;2(3):343-53.PMID: 15974900 [PubMed - indexed for MEDLINE]Related citations

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BB, Gulanski B.

Neurology. 1998 May;50(5):1222-30.PMID: 9595967 [PubMed - indexed for MEDLINE]Related citations

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

J Am Geriatr Soc. 2001 Dec;49(12):1590-9.PMID: 11843990 [PubMed - indexed for MEDLINE]Related citations

Is functional decline necessary for a diagnosis of Alzheimer's disease?

Park KW, Pavlik VN, Rountree SD, Darby EJ, Doody RS.

Dement Geriatr Cogn Disord. 2007;24(5):375-9. Epub 2007 Oct 3.PMID: 17914262 [PubMed - indexed for MEDLINE]Related citations

Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.

De Jesus Moreno Moreno M.

Clin Ther. 2003 Jan;25(1):178-93.PMID: 12637119 [PubMed - indexed for MEDLINE]Related citations

Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.

Fioravanti M, Flicker L.

Cochrane Database Syst Rev. 2001;(4):CD003159. Review.PMID: 11687175 [PubMed - indexed for MEDLINE]Related citations

Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies.

Mecocci P, Bladström A, Stender K.

Int J Geriatr Psychiatry. 2009 May;24(5):532-8.PMID: 19274640 [PubMed - indexed for MEDLINE]Related citations

Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the "real world" (CRONOS project): a 36-week follow-up study.

Bellelli G, Lucchi E, Minicuci N, Rozzini L, Bianchetti A, Padovani A, Trabucchi M.

Aging Clin Exp Res. 2005 Feb;17(1):54-61.PMID: 15847123 [PubMed - indexed for MEDLINE]Related citations

A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.

Suh GH, Ju YS, Yeon BK, Shah A.

Int J Geriatr Psychiatry. 2004 Sep;19(9):817-24.PMID: 15352138 [PubMed - indexed for MEDLINE]Related citations

Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.

Farlow M, Potkin S, Koumaras B, Veach J, Mirski D.

Arch Neurol. 2003 Jun;60(6):843-8.PMID: 12810489 [PubMed - indexed for MEDLINE]Related citations

The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.

Raskind MA, Cyrus PA, Ruzicka BB, Gulanski BI.

J Clin Psychiatry. 1999 May;60(5):318-25.PMID: 10362441 [PubMed - indexed for MEDLINE]Related citations